112 results ยท Page 1 of 5

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHYNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, chemotherapy-induced neuropathy, neoplasm, skin disorderRecruitingPhase 22026-10-09NCT06749210
Prehabilitation Physical Therapy and Relaxation Intervention Program to Promote Resiliency and Operative Success Among Adults Receiving Lung Cancer Surgery, ROAR-LCS TrialResectable Lung Non-Small Cell CarcinomaRecruitingNot applicable2026-10-06NCT07584239
Studying the Impacts of Higher Taxes and Bans on Electronic Cigarettes to Improve Public HealthTobacco-Related CarcinomaNot yet recruitingNot applicable2026-10-06NCT07581041
A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer PatientsDigestive System Diseases, Digestive System Neoplasms, Low Anterior Resection Syndrome, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal carcinoma, rectal disorder, rectal neoplasmRecruitingNot applicable2026-10-06NCT06424522
DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic CancerBorderline Resectable Pancreatic Ductal AdenocarcinomaRecruitingPhase 1 / Phase 22026-10-05NCT07705919
Evaluating the Effect of Nicotine on Eye Movements and Related Behaviors in Electronic Cigarette Users, NICS-EYES TrialCigarette Smoking-Related CarcinomaRecruitingNot applicable2026-10-05NCT07604246
Prospective Multiomic Analysis in Small-Cell Lung CancerNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinomaRecruitingNot stated2026-10-02NCT07795411
A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint InhibitorsFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, renal cell carcinoma, respiratory system disorder, respiratory tract neoplasm, urinary system disorderActive, not recruitingNot stated2026-09-30NCT06630429
Impact of Novel vs. Usual Brand Menthol Cigarettes on Abuse LiabilityChemically-Induced Disorders, nicotine dependence, psychiatric disorder, substance-related disorderRecruitingNot applicable2026-09-24NCT07564648
Spine Oncology RegistryNeoplasms by Site, central nervous system cancer, central nervous system disorder, neoplasm, nervous system disorder, spinal cord cancer, spinal cord disorder, spinal cord neoplasmRecruitingNot stated2026-09-24NCT07225491
Imaging and Blood-Based Biomarkers for the Evaluation of Early Signs of Myocardial Injury After Thoracic Radiation TherapyDigestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, gastroesophageal cancer, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmActive, not recruitingNot stated2026-09-24NCT05717998
Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphomaclassic Hodgkin lymphomaActive, not recruitingPhase 22026-09-24NCT02940301
Blessing Stem Cells to Improve Spiritual Well Being and Quality of Life for Patients Undergoing Hematopoietic Stem Cell TransplantationHematopoietic and Lymphatic System Neoplasm; Malignant Solid NeoplasmNot yet recruitingNot applicable2026-09-23NCT07835841
Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk WallResectable Liposarcoma; Resectable Soft Tissue Sarcoma; Resectable Undifferentiated Pleomorphic SarcomaNot yet recruitingPhase 32026-09-16NCT07823491
A Novel Tobacco Cessation Resource for Smokers With a Diagnosed or Suspected Thoracic Cancerthoracic cancerActive, not recruitingNot applicable2026-09-15NCT07455513
Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung CancerNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 12026-09-15NCT04780568
Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or CholangiocarcinomaBiliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, biliary tract disorder, carcinoma, cholangiocarcinoma, epithelial neoplasm, gallbladder disorder, gallbladder neoplasm, neoplasmRecruitingPhase 22026-09-10NCT07780838
Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After InductionHemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasmRecruitingPhase 1 / Phase 22026-09-09NCT04049539
Messages That Motivate: Communicating Alcohol-Related Breast Cancer Risk to Young Adult WomenAlcohol; Behavior, Risk; Cancer Prevention; Communication; Message PerceptionNot yet recruitingNot applicable2026-09-03NCT07802054
Minoxidil With or Without Low-Level Red-Light Therapy for Improving Chemotherapy-Induced Alopecia in Breast Cancer Patientschemotherapy-induced alopeciaNot yet recruitingPhase 22026-09-02NCT07594678
The Abuse Liability of IQOS Heated Tobacco Products Among Adults Who SmokeTobaccoRecruitingNot applicable2026-08-31NCT07688304
Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, and Chronic Lymphocytic LeukemiaB-cell chronic lymphocytic leukemia, Carcinogenesis, Cell Transformation, Neoplastic, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, blast phase chronic myelogenous leukemia, BCR-ABL1 positive, bone marrow disorder, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, myeloid leukemia, neoplasmActive, not recruitingPhase 12026-08-26NCT07166419
THRIVE Study: Understanding How Oral Nicotine Pouches Affect Public HealthTobacco-Related CarcinomaRecruitingPhase 42026-08-17NCT07503925
Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum ChemotherapyAdnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorderRecruitingEarly phase 12026-08-17NCT07144826
Informing Oral Nicotine Pouch Regulations to Promote Public HealthTobacco-Related CarcinomaRecruitingPhase 22026-08-17NCT06315881